TVTX logo

Travere Therapeutics (TVTX) Retained Earnings

Annual Retained Earnings

-$1.45 B
-$321.55 M-28.57%

December 31, 2024


Summary


Performance

TVTX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Quarterly Retained Earnings

-$1.45 B
-$60.26 M-4.35%

December 1, 2024


Summary


Performance

TVTX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TVTX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.6%-28.6%
3 y3 years-88.9%-28.6%
5 y5 years-247.5%-28.6%

TVTX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-88.9%at low-88.9%at low
5 y5-year-247.5%at low-248.2%at low
alltimeall time<-9999.0%at low<-9999.0%at low

Travere Therapeutics Retained Earnings History

DateAnnualQuarterly
Dec 2024
-$1.45 B(+28.6%)
-
Dec 2024
-
-$1.45 B(+4.3%)
Sep 2024
-
-$1.39 B(+4.1%)
Jun 2024
-
-$1.33 B(+5.6%)
Mar 2024
-
-$1.26 B(+12.1%)
Dec 2023
-$1.13 B(+11.0%)
-$1.13 B(+8.7%)
Sep 2023
-
-$1.04 B(-12.7%)
Jun 2023
-
-$1.19 B(+7.8%)
Mar 2023
-
-$1.10 B(+8.5%)
Dec 2022
-$1.01 B(+32.4%)
-$1.01 B(+6.9%)
Sep 2022
-
-$948.40 M(+7.9%)
Jun 2022
-
-$878.74 M(+8.3%)
Mar 2022
-
-$811.71 M(+6.0%)
Dec 2021
-$765.97 M(+30.7%)
-$765.97 M(+7.2%)
Sep 2021
-
-$714.39 M(+5.3%)
Jun 2021
-
-$678.75 M(+6.1%)
Mar 2021
-
-$639.74 M(+9.2%)
Dec 2020
-$585.88 M(+40.7%)
-$585.88 M(+26.2%)
Sep 2020
-
-$464.25 M(+5.1%)
Jun 2020
-
-$441.70 M(+6.3%)
Mar 2020
-
-$415.64 M(-0.2%)
Dec 2019
-$416.44 M(+54.2%)
-$416.44 M(+7.8%)
Sep 2019
-
-$386.19 M(+10.4%)
Jun 2019
-
-$349.69 M(+12.4%)
Mar 2019
-
-$310.99 M(+15.2%)
Dec 2018
-$270.02 M(+52.0%)
-$270.02 M(+2.8%)
Sep 2018
-
-$262.56 M(+26.2%)
Jun 2018
-
-$208.05 M(+12.0%)
Mar 2018
-
-$185.72 M(+4.5%)
DateAnnualQuarterly
Dec 2017
-$177.66 M(+57.1%)
-$177.66 M(+11.0%)
Sep 2017
-
-$160.04 M(+12.5%)
Jun 2017
-
-$142.24 M(+10.3%)
Mar 2017
-
-$129.01 M(+14.1%)
Dec 2016
-$113.06 M(+73.5%)
-$113.06 M(+8.2%)
Sep 2016
-
-$104.45 M(+55.1%)
Jun 2016
-
-$67.34 M(+24.8%)
Mar 2016
-
-$53.94 M(-17.2%)
Dec 2015
-$65.15 M(-63.6%)
-$65.15 M(+3.9%)
Sep 2015
-
-$62.68 M(-62.7%)
Jun 2015
-
-$168.26 M(+17.9%)
Mar 2015
-
-$142.73 M(-20.3%)
Dec 2014
-$179.18 M(+162.6%)
-$179.18 M(+20.1%)
Sep 2014
-
-$149.13 M(+15.1%)
Jun 2014
-
-$129.58 M(-6.1%)
Mar 2014
-
-$138.06 M(+102.3%)
Dec 2013
-$68.24 M(+103.0%)
-$68.24 M(+25.7%)
Sep 2013
-
-$54.30 M(+25.1%)
Jun 2013
-
-$43.40 M(+13.2%)
Mar 2013
-
-$38.35 M(>+9900.0%)
Dec 2012
-$33.61 M(>+9900.0%)
-
Nov 2012
-
-$146.80 K(+2.6%)
Aug 2012
-
-$143.10 K(+2.5%)
May 2012
-
-$139.60 K(+2.6%)
Feb 2012
-
-$136.10 K(+3.3%)
Feb 2012
-$136.10 K(+12.2%)
-
Nov 2011
-
-$131.80 K(+2.7%)
Aug 2011
-
-$128.30 K(+5.8%)
Feb 2011
-$121.30 K
-$121.30 K

FAQ

  • What is Travere Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Travere Therapeutics?
  • What is Travere Therapeutics annual retained earnings year-on-year change?
  • What is Travere Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Travere Therapeutics?
  • What is Travere Therapeutics quarterly retained earnings year-on-year change?

What is Travere Therapeutics annual retained earnings?

The current annual retained earnings of TVTX is -$1.45 B

What is the all time high annual retained earnings for Travere Therapeutics?

Travere Therapeutics all-time high annual retained earnings is -$121.30 K

What is Travere Therapeutics annual retained earnings year-on-year change?

Over the past year, TVTX annual retained earnings has changed by -$321.55 M (-28.57%)

What is Travere Therapeutics quarterly retained earnings?

The current quarterly retained earnings of TVTX is -$1.45 B

What is the all time high quarterly retained earnings for Travere Therapeutics?

Travere Therapeutics all-time high quarterly retained earnings is -$121.30 K

What is Travere Therapeutics quarterly retained earnings year-on-year change?

Over the past year, TVTX quarterly retained earnings has changed by -$321.55 M (-28.57%)